Keyphrases
Roux-en-Y Gastric Bypass
100%
Glucagon-like
100%
Glucose-dependent Insulinotropic Polypeptide
100%
Glucose Tolerance
100%
Sitagliptin
44%
Exendin (9-39)
33%
Cell Function
33%
A1 Receptor
22%
Placebo
22%
Dipeptidyl peptidase-4 (DPP-4)
22%
Blockage
22%
Glucose Excursion
11%
Glucagon-like peptide-1 Receptor (GLP-1R)
11%
Receptor Antagonism
11%
Randomized Placebo-controlled Trial
11%
Glucose-tolerant
11%
Meal Tolerance Test
11%
Postprandial Glucose
11%
Glucose-lowering Drugs
11%
Concurrent Administration
11%
Postprandial State
11%
Receptor Antagonist
11%
Glucagon Secretion
11%
Hyperglucagonemia
11%
Insulin
11%
Medicine and Dentistry
Roux-en-Y Gastric Bypass
100%
Glucagon Like Peptide 1
100%
Gastric Inhibitory Polypeptide
100%
Glucose Tolerance
100%
Sitagliptin
57%
Exendin 9
42%
Cell Function
42%
Placebo
42%
Glucagon Like Peptide 1 Receptor
28%
Infusion
14%
Postprandial State
14%
Test Meal
14%
Hyperglucagonemia
14%
Glucagon Release
14%
Secretion (Process)
14%
Receptor Antagonist
14%
Agricultural and Biological Sciences
Glucose Tolerance
100%
Gastric Inhibitory Polypeptide
100%
Glucagon-Like Peptide-1
100%
Placebo
42%
Glucagon-Like Peptide 1 Receptor
28%
Cross-over Studies
14%
Postprandial State
14%
Glucagon
14%